Important points in virus research using recombinant DNA technology

DOI Web Site PubMed
  • NIKAIDO Takahiko
    Deputy Director Office for Bioethics and Biosafety, Life Science Division, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology of Japan
  • TAKEUCHI Kaoru
    Department of Infection Biology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba

Bibliographic Information

Other Title
  • ウイルスを用いた遺伝子組換え実験を行なう際の留意事項
  • ウイルス オ モチイタ イデンシ クミカエ ジッケン オ オコナウ サイ ノ リュウイ ジコウ

Search this article

Abstract

Cartagena Protocol on Biosafety to the Convention on Biological Diversity seeks to protect biological diversity from potential risks posed by living modified organisms (LMOs) resulting from modern biotechnology. This protocol was ratified in Japan after establishing domestic law and regulations for the protocol. In the domestic law, use of LMOs is classified into type 1 use (use without containment measures) and type 2 use (use with containment measures). According to the domestic law, most of experiments using recombinant viruses are required for the approval of the Minister. In this article, we will explain Cartagena Protocol and the Japanese domestic low and indicate an example of application form for the approval of the Minister.

Journal

  • Uirusu

    Uirusu 57 (1), 91-100, 2007

    The Japanese Society for Virology

Keywords

Details 詳細情報について

Report a problem

Back to top